Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer.
about
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantationHow do chemotherapeutic agents damage the ovary?Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapySerum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic reviewEstimates of young breast cancer survivors at risk for infertility in the U.S.Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservationA highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patientsChallenges and considerations in optimizing ovarian stimulation protocols in oncofertility patients.Fertility preservation in women with cancer.Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatinOvarian stimulation in patients with breast cancerExperiencing reproductive concerns as a female cancer survivor is associated with depression.Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Fertility preservation in reproductive-age women facing gonadotoxic treatments.Understanding Fertility in Young Female Cancer Patients.Hypothyroidism after cancer and the ability to meet reproductive goals among a cohort of young adult female cancer survivors.Menses resumption after cancer treatment-induced amenorrhea occurs early or not at allChemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma.Fertility counseling of young breast cancer patients.Oncofertility in Canada: the impact of cancer on fertilityWhy Healthcare Providers Should Focus on the Fertility of AYA Cancer Survivors: It's Not Too Late!Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort.Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?Fertility issues in cancer survivorship.The promise of organ and tissue preservation to transform medicine.Response to ovarian stimulation is not impacted by a breast cancer diagnosis.Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors.The risk of preterm birth and growth restriction in pregnancy after cancer.Which female cancer patients fail to receive fertility counseling before treatment in the state of Georgia?Fertility Sparing Surgery for Localized Ovarian Cancers Maintains an Ability to Conceive, but is Associated With Diminished Reproductive Potential.Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Fertility preservation with ovarian stimulation protocols prior to cancer treatment.Menstrual restoration in severe panhypopituitarism many years after cranial irradiation for suprasellar germinoma.Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients.Acute Menopausal Symptoms in Young Cancer Survivors Immediately following Chemotherapy.Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study.Cancer survivors of gynecologic malignancies are at risk for decreased opportunity for fertility preservation.
P2860
Q26827226-F81B8387-BFC4-4D33-BF1E-1293AACD4A9BQ28267696-D95248CA-E592-4442-8678-811A020F524EQ28383325-543BF147-D2EE-486B-A334-F293F8FECD12Q28384104-70DDEE05-D307-45AB-B862-F4FDDE57A63AQ34005150-7E0FA6FE-290F-48AF-A604-D512B803BB8FQ34127500-F2568927-ECB4-4C1D-ACD2-A7B3D46D498FQ34199333-F4A55C69-74D3-44D8-9A28-363F24C65603Q34550633-7761F514-7F44-493D-8090-225F82196599Q34637134-E5EA5D66-7450-43F4-BE0C-FF74C9DD9DDAQ34729392-1FA34B03-4B49-4C9F-B249-3ED8F63E5F18Q34905992-020EFB41-7BCC-43D7-BB14-C1CEAE0D7856Q35106191-920FE810-D9CD-4404-A3A1-73132342D17FQ35154987-6833D90A-6139-446A-B287-739189A43319Q35766397-12668C69-90DC-4689-921B-0F6EE78685E3Q35815806-C273E0FE-4211-431F-A9C3-013B7ADE29D7Q35934317-85370B58-FCE3-4FEE-A5A0-23CBF0F54F82Q36218039-3D845DB2-0767-4427-BA4C-38BB557CD977Q36456034-E914278C-05BE-40C2-BE33-900B96FE1069Q36655965-8EA874C7-7A18-4815-AC9C-22919CB1B34CQ36708416-CEA0615B-18B4-4C63-8CDE-FB67B1CFC7D7Q36963384-920643D5-06D7-45B6-AA2C-59F2AA0F55CFQ37056902-E89CE877-4B91-4469-8FB3-925C0B59B5BEQ37218794-C9D69BB4-2847-4CA3-B002-6A9137626830Q37354539-122226E7-DCC4-4CBA-AE68-5662E770D444Q37679148-2299FC00-14F8-4CA9-BBD0-7F55AEB218D0Q38194105-B00F1FD8-9C16-454D-8210-8648DA666EBAQ38673700-4EB4F750-8E03-4BA5-BD11-62F94CF0CCD9Q38999007-B662F654-99AA-4432-B35E-87BBAE88C9A0Q39592988-DCB963C7-6555-42BC-A5DC-85F6E5F5B2C4Q40072620-5411D564-3F26-4E24-A723-3234C3A3ADFEQ40563442-9DE1796A-3E6D-4633-B271-A8BCEB9B26F9Q40716717-19C4D352-AC5B-48FF-80E2-31D031FC9A58Q41439153-A8002D29-6474-402E-9A3A-A6FB66207FEEQ46144166-B0A3CF13-5D5F-4B44-8773-32837D966DB1Q46812916-DDE9F738-15C3-48DD-9675-B629C5E79AC5Q47162199-769E47E2-3A04-43E7-8BAE-538E48C31CC9Q47789026-C92E11EC-4C40-4029-ADB1-C12B8E226D59Q49380779-501E9CE0-5473-426E-ACAB-2EB68D655942Q50984893-D6F6DE33-B498-4DEA-A1D3-B4FAF82F78C4Q55174705-3540B0E2-A1B7-4677-90FE-C553F34AE364
P2860
Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Acute ovarian failure underest ...... going chemotherapy for cancer.
@ast
Acute ovarian failure underest ...... going chemotherapy for cancer.
@en
type
label
Acute ovarian failure underest ...... going chemotherapy for cancer.
@ast
Acute ovarian failure underest ...... going chemotherapy for cancer.
@en
prefLabel
Acute ovarian failure underest ...... going chemotherapy for cancer.
@ast
Acute ovarian failure underest ...... going chemotherapy for cancer.
@en
P2093
P2860
P356
P1433
P1476
Acute ovarian failure underest ...... going chemotherapy for cancer.
@en
P2093
A Jo Chien
Charles E McCulloch
Erin E Ebbel
Joseph M Letourneau
Kutluk H Oktay
Marcelle I Cedars
Michelle E Melisko
Mitchell P Rosen
Patricia P Katz
P2860
P304
P356
10.1002/CNCR.26403
P407
P577
2011-08-17T00:00:00Z